LIXTE Biotechnology Holdings, Inc. Investor Relations LIXTE Biotechnology Holdings, Inc. has just released the following news: LIXTE RECEIVES U.S. PATENT ISSUE NOTIFICATION FOR IMMUNE ONCOLOGY Click here to read the full article If you have any questions, or would like to contact Investor Relations, please reply to this email. LIXTE Biotechnology Holdings, Inc. 680 E Colorado Blvd., Suite 180, Pasadena, CA 91101 United States of America Change Your